Breast Cancer Nomograms: Prediction for a Low-risk and a High-risk Oncotype DX Recurrence Score
The updated nomogram/calculator is available on-line at https://utgsm.shinyapps.io/OncotypeDXCalculator
- The nomogram/calculator was updated based on the TAILORx clinical trial results:
Oncotype DX recurrence score 0-25 is classified as a low-risk score
Oncotype DX recurrence score 26-100 is classified as a high-risk score. - The updated nomogram/calculator was developed and validated from 84,339 patients’ data (National Cancer Data Base).
- When the nomogram/calculator calculated probability is within 85% to 100% range, the nomogram/calculator correctly assigns 92.7% of cases to the Oncotype DX low-risk or high-risk score (see Table 2 and Table 3 in the supporting publication).
Supporting Publication
Orucevic A, Bell JL, King M, McNabb AP, Heidel RE Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data. Accepted for Publication, The Breast (2019) https://doi.org/10.1016/j.breast.2019.05.006
.
DISCLAIMER
This website and the nomograms are provided for general health information only and are not to be used as a substitute for diagnosis or medical advice. All questions should be addressed directly to your individual healthcare provider. In using this website and the nomograms, you agree that neither The University of Tennessee Medical Center ("UTMC") nor any other party is or will be liable or otherwise responsible for any decision made, or any action taken, or any action not taken due to your use of any information presented in the nomograms.
Use of this website including the nomograms does not create an expressed or implied physician-patient relationship.
UTMC does not assume any risk for your use of website and/or its nomograms or the information contained herein. UTMC makes no warranties or representations, expressed or implied, regarding the accuracy, completeness, timeliness, or usefulness of any information contained or referenced in the website and/or the nomograms.
You are advised to consult with a healthcare provider prior to making any decisions, or undertaking any actions or not undertaking any actions related to any healthcare problem or issue you might have at any time, now or in the future.